Pharma Marketing Network

DECEMBER 13, 2024

Imagine a diabetes patient sharing their experience with Ozempicit resonates far better than generic ads. White Papers and Webinars: Provide HCPs with resources that dive into drug efficacy and research. Patient Stories: Share real-life success stories. Educational Content In healthcare advertising, knowledge builds trust.

Dosage 52

Dosage Communication Diabetes 52

Pharma Marketing Network

DECEMBER 19, 2024

For instance, targeting a diabetes drug like Jardiance involves identifying adults struggling with Type 2 diabetes and tailoring messages about improved glycemic control. Education and Training: Provide resources like webinars or white papers to engage HCPs effectively.

HIPAA 52

HIPAA Diabetes Communication 52

Pharma Marketing Network

DECEMBER 13, 2024

Example: For a branded diabetes drug like Ozempic, you could design campaigns encouraging patients to use a savings card. For HCPs: Share clinical summaries, white papers, or treatment guidelines. Why CPA is Perfect for Pharma Marketing 1. Payment happens only when a patient redeems it, ensuring ROI.

Scheduling Appointments 52

Scheduling Appointments Diabetes 52

PharmaState Academy

AUGUST 9, 2023

Surprisingly, secondary research in reputed medical journals indicated that many chronic conditions like hypertension and diabetes had depression as a coexisting problem. For example, “Ask your next pre-diabetic person to join ‘The Prediabetic Club’ to delay progression to diabetes.” But then there was a big challenge.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Diabetes 52

PharmaShots

FEBRUARY 14, 2023

For example, if you develop a medicine that can treat diabetes and you desire FDA approval, the path is standardized and clearly laid out. Whitney Stewart: Our joint white paper with DTA was intentionally made regional-agnostic and is intended to apply across the globe. In the U.S.,

Communication 40

Communication Diabetes 40

PharmaShots

FEBRUARY 14, 2023

For example, if you develop a medicine that can treat diabetes and you desire FDA approval, the path is standardized and clearly laid out. Whitney Stewart: Our joint white paper with DTA was intentionally made regional-agnostic and is intended to apply across the globe. In the U.S.,

Communication 40

Communication Diabetes 40

Pharmaceutical Technology

MARCH 6, 2023

For example, in the Targeting Aging with Metformin (TAME) Trial , a series of six-year studies, the diabetes drug metformin will be studied for its effects in preventing age-related conditions such as cardiovascular disease, cancer, impaired cognition, and mortality.

Labelling 145

Labelling Communication Diabetes Pharmaceutical Companies 145

Pharmaceutical Technology

NOVEMBER 30, 2022

The drug was approved to treat type 2 diabetes mellitus in May. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Diabetes Labelling Communication 105

Pharmaceutical Technology

NOVEMBER 30, 2022

The drug was approved to treat type 2 diabetes mellitus in May. High rates of obesity place a major burden on healthcare systems as the condition is associated with many major health complications like type 2 diabetes, hypertension, non-alcoholic fatty liver disease, and other bodily dysfunctions. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Diabetes Labelling Communication 98

Pharmaceutical Technology

MARCH 22, 2023

Generic drug companies have already warned that manufacturing some products will become unsustainable, and they may cease manufacturing a few, such as generic diabetes and cancer drugs.

Pharmaceutical Manufacturing 105

Pharmaceutical Manufacturing Packaging Communication Diabetes 105

Pharmaceutical Technology

MAY 3, 2023

In recent years, first generics have improved patient access to essential treatments and offered affordable treatment options for patients with multiple sclerosis, asthma, heart disease, diabetes, and even the flu. However, business and other considerations may have an impact on how quickly a generic becomes available.

Generic Medicine 98

Generic Medicine Drug Development Communication Diabetes 98

Pharmaceutical Technology

MARCH 20, 2023

Rates of non-communicable diseases such as hypertension, cardiovascular disease, chronic respiratory diseases, diabetes, and cancers are also considered high throughout Africa. Consequently, there are relatively small patient pools for non-communicable diseases such as cancer, diabetes, heart disease, and Alzheimer’s.

Communication 52

Communication Diabetes Labelling 52

Pharmaceutical Technology

MARCH 21, 2023

The SGLT2 inhibitor is already approved to treat type 2 diabetes (T2D), chronic kidney disease (CKD), and heart failure with reduced ejection fraction (HFrEF) in patients with or without T2D. A few weeks later, the EC extended the approval label of AstraZeneca’s Forxiga (dapagliflozin) to include the treatment of symptomatic hearth failure.

Packaging 59

Packaging Vaccines Labelling Communication 59

Pharmaceutical Technology

FEBRUARY 28, 2023

Celnova Pharma is an Argentina-based pharmaceutical company that centres its work around rare diseases, oncology, central nervous system, diabetes and critical care. HRA RD’s new partnership will function to allow HRA RD to launch its rare disease products Ketoconazole HRA and Lysodren across Argentina, Chile and Peru.

Communication 52

Communication Diabetes Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JANUARY 15, 2023

The agency expanded the use of Eli Lilly’s Trulicity (dulaglutide) injection to include pediatric type 2 diabetes patients ages 10 years and older, to improve glycemic control as an adjunct to diet and exercise. The FDA passed several positive supplementary approval decisions involving younger patients.

Labelling 52

Labelling Packaging Communication Diabetes 52

Pharmaceutical Technology

JANUARY 11, 2023

Digital therapeutic apps are being built to help manage type 2 diabetes or assist with addiction. For example, he continues: “After knee surgery we can now provide the patient with an app that guides their daily recovery exercises, tracks any side effects they are experiencing, and warns them if they are doing too much or too little.”

Health and Personal Care Stores 52

Health and Personal Care Stores Hospitals Communication Medical Records 52

Pharmaceutical Technology

JANUARY 26, 2023

Patients with conditions with limited treatment options could one day be cured by these breakthrough therapeutics, with treatments for everything from cancers, Parkinson’s and Alzheimer’s to strokes, spinal cord injuries and diabetes.

Communication 52

Communication Diabetes Drug Development 52